Progyny, Inc. (NASDAQ:PGNY) Stake Lowered by State of Tennessee Department of Treasury

State of Tennessee Department of Treasury trimmed its stake in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 54.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,388 shares of the company's stock after selling 45,198 shares during the quarter. State of Tennessee Department of Treasury's holdings in Progyny were worth $645,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Signaturefd LLC grew its position in shares of Progyny by 1,355.0% during the fourth quarter. Signaturefd LLC now owns 1,455 shares of the company's stock worth $25,000 after buying an additional 1,355 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Progyny by 341.4% in the 4th quarter. GAMMA Investing LLC now owns 1,611 shares of the company's stock valued at $28,000 after purchasing an additional 1,246 shares in the last quarter. Nisa Investment Advisors LLC lifted its position in shares of Progyny by 108.4% during the 4th quarter. Nisa Investment Advisors LLC now owns 2,934 shares of the company's stock worth $51,000 after purchasing an additional 1,526 shares during the last quarter. Caitlin John LLC grew its stake in shares of Progyny by 2,974.8% during the fourth quarter. Caitlin John LLC now owns 3,290 shares of the company's stock worth $57,000 after purchasing an additional 3,183 shares in the last quarter. Finally, Natixis purchased a new position in Progyny in the fourth quarter valued at $69,000. Hedge funds and other institutional investors own 94.93% of the company's stock.

Progyny Trading Down 0.2 %

PGNY stock traded down $0.04 during trading on Tuesday, hitting $23.36. The company had a trading volume of 1,041,981 shares, compared to its average volume of 1,741,730. Progyny, Inc. has a fifty-two week low of $13.39 and a fifty-two week high of $33.84. The firm has a market capitalization of $2.00 billion, a price-to-earnings ratio of 40.28, a P/E/G ratio of 2.39 and a beta of 1.37. The business has a 50 day moving average of $21.90 and a 200 day moving average of $19.37.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. JPMorgan Chase & Co. boosted their target price on Progyny from $17.00 to $23.00 and gave the stock a "neutral" rating in a research note on Tuesday, January 28th. Bank of America boosted their target price on Progyny from $21.00 to $25.00 and gave the company a "buy" rating in a report on Tuesday, February 11th. Canaccord Genuity Group raised their price target on Progyny from $17.00 to $23.00 and gave the stock a "hold" rating in a research note on Friday, February 28th. Finally, BTIG Research raised Progyny from a "neutral" rating to a "buy" rating and set a $28.00 price objective for the company in a report on Monday, March 31st. Eight equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $23.64.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.